Search Results 7061-7070 of 25044 for oral
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Radiation Oncology ...
Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. Am J Transplant. 2013 Jun; 13 (6): ...
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
Use of osteoporosis therapies known to influence calcium and bone metabolism; i.e., bisphosphonate (oral or intravenous [IV]), denosumab, raloxifene, or ...
Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...
... oral antiviral prophylaxis. Arch Ophthalmol. 2010 Sep; 128 (9):1178-83. View PubMed; Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J ...
... oral cancer reconstruction. Related Articles. Cancer. Mayo Clinic experts present key cancer research findings at ASCO. Medical Innovation. New Mayo Venture ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.